Locations:
Search IconSearch
May 24, 2022/Digestive/Research

Anastomotic Configuration in Crohn’s Disease Surgery Does Not Influence Stricture Risk

Research reveals that diverting ostomy is also not a stricturing factor

18-DDI-5583-Shen-Hero-Image-650x450pxl_02

The risk of strictures following ileocecal resection for Crohn’s disease (CD) doesn’t appear to be influenced by the surgical approach to anastomosis or the use of a diverting ostomy, new research suggests.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Anastomotic and neoterminal ileal strictures are known consequences of CD recurrence following ileocolonic resection. Until now, little had been known regarding the role of anastomotic configuration in stricture formation, although some researchers had hypothesized that diverting ostomies or certain types of primary anastomoses might increase the stricture risk.

This new study refutes that premise.

“Simply put, we found that neither one influenced that risk. These are new findings in our field from a medical and surgical standpoint,” says study co-author Miguel Regueiro, MD, Chair of Cleveland Clinic’s Digestive Disease & Surgery Institute.

The results, Dr. Regueiro says, “reassure us that when a patient needs a temporary diverting ileostomy to allow for healing of infection and inflammation around the anastomosis, that’s OK since there is not a higher rate of stricture. And, if the surgeon’s preference is to do the anastomosis either end-to-end, side-to-side, or end-to-side, there’s no real difference between those in terms of the stricturing rates after surgery.”

Cleveland Clinic internal medicine resident Muhammad Zarrar Khan, MD, a coauthor of the study, presented the findings at the 2022 Digestive Disease Week annual meeting.

Methodology

The study involved 606 patients who underwent ileocecal resection for CD between 2009 and 2020 and who also underwent postoperative ileocolonoscopy. The procedures took place at three centers of expertise in colorectal surgery: Cleveland Clinic, the University of North Carolina (UNC) Chapel Hill, and New York University (NYU) School of Medicine. More than half of the patients were seen at Cleveland Clinic.

Advertisement

The patients had a median age at surgery of 34.5 years, just under half (47.5%) were male, and 41% were smokers — a factor believed to increase the risk for CD recurrence and strictures. About one in five was started on postoperative biologic prophylaxis.

A majority (n=426, or 70.3%) had a primary anastomosis at the time of resection, including 78 end-to-end, 117 end-to-side and 231 side-to-side. The rest had either diverting loop ileostomy (22.8%) or end ileostomy (6.9%).

Anastomotic strictures developed in a total of 18.2% of the 606 patients at a median time of 1,207.5 days post-surgery. 18.8% of the strictures occurred in patients with end-to-end anastomoses, 20.3% end-to-side and 16.8 side-to-side.

An unexpected outcome

Survival analysis showed that anastomotic configuration was not associated with stricture formation (p=0.098), even after controlling for the postoperative recurrence risk factors of biologic prophylaxis and use of a diverting ostomy.

This result was somewhat unexpected, since it had been thought that the end-to-end configuration might increase the risk for stricture because the inner diameter it creates is smaller than the other two types. “But this study did not show that,” Dr. Regueiro notes.

Moreover, compared to primary anastomosis, there was no difference in stricture formation for those receiving diverting loop (adjusted hazard ratio 1.36, p=0.19) or end ileostomy (0.35, p=0.14). This, too, was a bit of a surprise. “I was kind of expecting that diverting ostomies would ultimately develop more strictures after reconnection of the bowel. That had always been the theory,” Dr. Regueiro says.

Advertisement

Ongoing studies at Cleveland Clinic, some also in collaboration with UNC and NYU, are investigating the optimal surgeries and medications to prevent CD recurrence. Cleveland Clinic’s colorectal surgery program is the largest in the country, comprising 27 surgeons who operate on about 10,000 patients with inflammatory bowel disease annually.

Reassuring results

The research’s bottom line is that the choice of which anastomotic configuration to use and whether to employ a diverting ostomy should be guided by the surgeon’s experience and the patient’s individual requirements.

According to Dr. Regueiro, “This was a great study for us in the field going forward. We didn’t see differences in strictures and blockage, which I think is really important. The take-home message is do the right surgery for the patient, including diverting ostomy, if required.”

Advertisement

Related Articles

Illustration of J pouch
May 21, 2026/Digestive/Research

Ulcerative Colitis Patients with Pyoderma Gangrenosum Have Worse Outcomes with J-Pouch Surgery, Study Finds

Patients have a significantly higher risk of developing fistulas and experiencing future Crohn’s-like changes

Dr. Gorgun in operating room
May 20, 2026/Digestive/Research

Cleveland Clinic Colorectal Surgeons Develop a New Standardized Endoscopic Grading System for Rectal Cancer Response and Organ Preservation

Cleveland Clinic researchers developed an objective tool to assess response following total neoadjuvant therapy.

Patient speaking with physicians
May 11, 2026/Digestive/Research

Adherence to Lifestyle Changes Peaks One Month After Bariatric Surgery, Study Finds

Patients may benefit from booster appointments, psychological support

Dr. Aminian in OR
May 7, 2026/Digestive/Research

Metabolic Surgery May Reverse MASH Cirrhosis, Paired Biopsy Study Suggests

Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment

Dr. Regueiro speaking with patient
May 6, 2026/Digestive/Research

Patients With IBD Who Undergo Colon Cancer Surgery Have Higher Blood Clot Risk

Elevated risk persists for more than a year after surgery, plus more insights from the first study to quantify risk specifically for CRC surgery

Pharmacist filling order
May 5, 2026/Digestive/Research

Fenofibrate-UDCA Combination Therapy Safe and Effective for Primary Biliary Cholangitis

Large, retrospective study indicates improved outcomes after one and five years of treatment

Dr. Bhatt with clinician
April 28, 2026/Digestive/Innovation

Endorobotics Collaborative: A New Era in Gastrointestinal Procedures

Multidisciplinary collaboration is fueling breakthroughs in endoscopic and surgical technology

Dr. Kwan and Dr. Hashimoto performing Laparoscopic Liver Transplant Surgery
April 9, 2026/Digestive/Transplant

Transforming Liver Transplantation at Cleveland Clinic

A surge in transplants, advanced surgical techniques and multidisciplinary collaboration has helped shape and expand the Liver Transplant Program

Ad